Pacific Biosciences Of California | PACB - Actif À Court Terme





Actif À Court Terme Changement Date
Agilent USD 4.69B 70M 2026-06
Bruker USD 2.22B 121.4M 2026-06
Danaher USD 13.38B 554M 2026-06
General Electric Aerospace USD 39.7B 664M 2026-06
Illumina USD 2.83B 96M 2026-06
Myriad Genetics USD 289M 23.8M 2026-06
Pacific Biosciences Of California USD 338.64M 30.88M 2026-06
Quidel USD 1.38B 400K 2026-06
Revvity USD 2.3B 169.4M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Standard Biotools USD 521.45M 67.19M 2026-03
Thermo Fisher Scientific USD 23.36B 1.05B 2026-06
Waters USD 3.9B 186M 2026-06